Login / Signup

Risk-Benefit of IBD Drugs: A Physicians and Patients Survey.

Ferdinando D'AmicoSophie VieujeanBenedicte CaronLaurent Peyrin-BirouletSilvio Danese
Published in: Journal of clinical medicine (2023)
Physicians and patients have different priorities in evaluating the benefit-risk balance of a new therapy.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • primary care
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • stem cells
  • patient reported outcomes